5/27/2025Juri Bio Secures Global Rights to Novel Prostate Cancer Immunotherapy ...

5/27/2025FDA Approves China's First Homegrown Painkiller Qamzova

5/27/2025Recce Pharma Secures Key China Patent

5/27/2025Servier Acquires BioNova's Menin Inhibitor BN104

5/27/2025Innovent's Mazdutide Demonstrates Significant Weight Loss in Phase 3 G...

5/27/2025Zai Lab's ZL-1310 Shows Promising Results in Extensive-Stage SCLC

5/27/2025Insilico Medicine Unveils AI-Designed ENPP1 Inhibitor ISM5939

5/27/2025Henlius Reports Promising Phase 1 Results for PD-L1-Targeting ADC HLX4...

5/27/2025CTTQ's Anlotinib Combination Shows Promise

5/23/2025Vigene and Merz Expand Strategic Partnership Across Greater China

5/23/2025CARsgen's Satri-cel CAR T Demonstrates Significant Efficacy in GC/GEJ

5/23/20253SBio's Bispecific Antibody SSGJ-707 Shows Promising Results in Advanc...

5/23/2025Dizal's DZD6008 Shows Promising Results in EGFR-Mutant NSCLC with Brai...

5/22/2025InnoVec Secures Series A Funding to Advance AI-Driven Gene Therapy Pla...

5/22/2025NMPA Approves Bayer's Eylea 8 mg for nAMD

5/22/2025China Approves Raynovent's Onradivir for Adult Influenza A Treatment

5/22/2025NMPA Grants Conditional Approval to JacoBio's Glecirasib for KRAS G12C...

5/21/2025Accropeutics Reports Phase 2 Psoriasis Success with TYK2/JAK1 Inhibito...

5/21/2025China Approves InnoCare's Tafasitamab for R/R DLBCL

5/20/2025CSPC Pharma's JMT106 Approved for Clinical Trials in China and the U.S...

5/20/2025Innovent's XNW5004 Receives Breakthrough Therapy Designation

5/20/20253SBio Advances SSGJ-707 into Phase 3 Trial for NSCLC

5/20/2025ArkBio Announces Positive Phase II Results of AK3280

5/20/2025BeiGene Advances BTK Degrader BGB-16673 in Head-to-Head Phase 3 Trial

5/20/2025Nuance Reports Positive Top-Line Results from Phase 3 Trial of Ensifen...

5/16/2025Nuance Pharma Reports Positive Phase 3 Results for Ensifentrine in Chi...

5/16/2025NMPA Approves CANbridge's Velaglucerase Beta for Gaucher Disease

5/16/2025China Approves Xuanzhu Bio's Birociclib for HR+/HER2- Advanced Breast ...

5/16/2025China Approves Haisco Pharma's Anrikefon (HSK21542) for Postoperative ...

5/15/2025NMPA Approves Novartis' Scemblix for First-Line Treatment of Chronic M...

Page:2/14 Total number of articles:409: [First][<<] [1] [2] [3] [4] [5] [>>] [End]